Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
STATE STREET CORP
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 2,050,782 | 1,187 | 51,905,292,000 | 14,069,768,000 | $25,310.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 2,049,595 | 433,142 | 37,835,524,000 | 37,791,880,000 | $18,460.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,616,453 | -163,340 | 43,644,000 | 19,047,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,779,793 | 238,356 | 24,597,000 | -5,461,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 1,541,437 | -25,409 | 30,058,000 | 4,487,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,566,846 | 59,008 | 25,571,000 | -16,437,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,507,838 | 71,394 | 42,008,000 | -568,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,436,444 | 85,278 | 42,576,000 | 4,811,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,351,166 | -119,110 | 37,765,000 | -3,903,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 1,470,276 | 129,870 | 41,668,000 | 7,970,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 1,340,406 | -9,674 | 33,698,000 | 729,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 1,350,080 | 191,025 | 32,969,000 | 15,815,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 1,159,055 | 103,665 | 17,154,000 | 25,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 1,055,390 | 33,269 | 17,129,000 | 3,841,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 1,022,121 | 83,049 | 13,288,000 | 1,108,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 939,072 | 125,629 | 12,180,000 | -640,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 813,443 | 137,221 | 12,820,000 | -792,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 676,222 | -43,924 | 13,612,000 | -4,283,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 720,146 | 50,821 | 17,895,000 | -477,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 669,325 | 207,965 | 18,372,000 | 1,881,000 | $27.45 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 461,360 | -4,737 | 16,491,000 | 3,650,000 | $35.74 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 466,097 | 13,607 | 12,841,000 | 897,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 452,490 | 2,637 | 11,944,000 | 2,588,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 449,853 | 124,705 | 9,356,000 | 2,627,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 325,148 | 17,410 | 6,729,000 | 1,739,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 307,738 | -121,744 | 4,990,000 | -850,000 | $16.22 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 429,482 | -97,834 | 5,840,000 | -3,366,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 527,316 | 301,210 | 9,206,000 | 2,473,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 388,796 | 162,690 | 13,281,000 | 6,548,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 226,106 | 32,885 | 6,733,000 | 548,000 | $29.78 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 193,221 | 81,796 | 6,185,000 | 3,877,000 | $32.01 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 111,425 | 7,683 | 2,308,000 | 552,000 | $20.71 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 103,742 | 4,883 | 1,756,000 | -158,000 | $16.93 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 98,859 | 7,630 | 1,914,000 | -1,189,000 | $19.36 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 91,229 | 25,734 | 3,103,000 | 1,040,000 | $34.01 |
| << Prev Next >> |
|